Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-1026
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study ; volume:3 ; number:1 ; day:19 ; month:12 ; year:2019 ; pages:1-12 ; date:12.2019
BMC Rheumatology ; 3, Heft 1 (19.12.2019), 1-12, 12.2019
- Urheber
-
Gavan, Sean P.
Daker-White, Gavin
Payne, Katherine
Barton, Anne
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-019-0097-0
- URN
-
urn:nbn:de:101:1-2020030222344390911926
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gavan, Sean P.
- Daker-White, Gavin
- Payne, Katherine
- Barton, Anne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy